Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

The First Amendment's guarantees are not absolute. A person cannot “shout 'fire!' in a crowded theater,” and put the lives of ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Human metapneumovirus (HMPV), a flu-like virus causing mild respiratory infections, is seeing a rise in cases in China ...

Their warning comes as the US experiences its own increase in HMPV cases, with positive test percentages ... molecular tests like PCR tests, which are used to detect Covid.

For infectious disease specialists, HMPV is a well-known pathogen and has been circulating in most countries, including India, for quite some time ...

(RTTNews) - Indian shares look set to open on a positive note Monday after U.S. stocks showed a strong move back to the upside during trading on Friday. That said, a cautious undertone may prevail ...

However health and fitness guru Dr Michael Mosley believed that wasn't the case. In fact he said he got the best results by checking the scales several times a week. The presenter and podcast host ...